Last Posted: Dec 02, 2018
- 5 Things to Know About Hereditary Pancreatic Cancer
Pancreatic Cancer Action Network, November 2018 - A Novel Multiplex droplet digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens.
Alcaide Miguel et al. The Journal of molecular diagnostics : JMD 2018 Nov - Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel Elena M et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Nov JCO1801489 - The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.
Parkin Ashleigh et al. Diseases (Basel, Switzerland) 2018 Nov 6(4) - The impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.
Shirasu Hiromichi et al. Cancer science 2018 Nov - Take it from a genetic counselor: 23andMe's health reports are dangerously incomplete
SC Hopkins, October 26, LA Times, October 2018 - Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis.
Grassi Elisa et al. International journal of oncology 2018 Jun 52(6) 1972-1980 - CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.
Szlachta Karol et al. Nature communications 2018 Oct 9(1) 4275 - High prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.
Bannon Sarah A et al. Cancer prevention research (Philadelphia, Pa.) 2018 Oct - Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Walker Evan J et al. Familial cancer 2018 Sep
.png)
No hay comentarios:
Publicar un comentario